Biosino Bio-Technology and Science Incorporation (HKG:8247)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.500
0.00 (0.00%)
At close: Apr 29, 2026
548.15%
Market Cap 506.48M
Revenue (ttm) 205.08M
Net Income (ttm) -56.91M
Shares Out 144.71M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 58,000
Average Volume 145,700
Open 3.460
Previous Close 3.500
Day's Range 3.460 - 3.500
52-Week Range 0.510 - 7.000
Beta 0.43
RSI 40.56
Earnings Date Mar 31, 2026

About HKG:8247

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a a strategic cooperation agreeme... [Read more]

Sector Healthcare
Founded 1988
Employees 471
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8247
Full Company Profile

Financial Performance

In 2025, HKG:8247's revenue was 184.29 million, a decrease of -29.95% compared to the previous year's 263.07 million. Losses were -51.14 million, 20.2% more than in 2024.

Financial numbers in CNY Financial Statements

News

There is no news available yet.